Research technician Michael Swift examines cells in the Cell Processing Facility, where immune-based therapies are manufactured according to
U. S. Food and Drug Administration specifications. Immunotherapy is one of four research intiatives the center has targeted for strategic fund raising. Photo by Todd Mcnaught
|